Liminatus Pharma LLCLIMN
13F holders, Q4 2025 (December 31)12holders +2
4new positions
2sold out
1famous investor
$0.61avg. 13F price*
At the end of Q4 2025, 12 institutions reported holding Liminatus Pharma LLC (LIMN) in their 13F filings, up 2 from Q3 2025. 4 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($45K), Citadel Advisors ($43K) and Geode Capital Management, LLC ($40K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Liminatus Pharma LLC
- CUSIP
- 53271X108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $72K |
| Exits | 2 | $84K |
All 13F filers, Q3 2025 → Q4 2025: 126,462 shares bought and 71,193 shares sold, net +55,269 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Vanguard Group Inc. | 0.00% | No change | 73,424 | $45K |
| Citadel Advisors | 0.00% | New | 70,930 | $43K |
| Geode Capital Management, LLC | 0.00% | Add +2.1% | 65,051 | $40K |
| Two Sigma Investments, LP | 0.00% | New | 35,284 | $22K |
| UBS Group AG | 0.00% | Reduce -52.1% | 19,395 | $12K |
| State Street Corp. | 0.00% | No change | 19,000 | $12K |
| BlackRock, Inc. | 0.00% | No change | 13,255 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 11,875 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +381.8% | 8,903 | $5K |
| Bank of America Corp. | 0.00% | Reduce -35.3% | 44 | $27 |
| Farther Finance Advisors, LLC | 0.00% | No change | 31 | $19 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is LIMN's weight in each manager's 13F, not the share of Liminatus Pharma LLC the manager owns.